SofWave Medical Ltd. (SOFWF)

OTCMKTS · Delayed Price · Currency is USD
12.75
0.00 (0.00%)
Mar 26, 2026, 9:30 AM EST
Market Cap429.33M +141.8%
Revenue (ttm)87.64M +46.9%
Net Income5.49M
EPS0.14
Shares Outn/a
PE Ratio78.24
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume3,803
Open12.75
Previous Close12.75
Day's Range12.75 - 12.75
52-Week Range4.35 - 12.75
Betan/a
RSI85.65
Earnings Daten/a

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. The company was incorporated in 2015 a... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2015
Employees 126
Stock Exchange OTCMKTS
Ticker Symbol SOFWF

Financial Performance

Financial Statements

News

SofWave Medical Ltd. (SOFWF) Q3 2025 Earnings Call Transcript

SofWave Medical Ltd. (OTC:SOFWF) Q3 2025 Earnings Call November 4, 2025 7:00 AM EST Company Participants Shimon Eckhouse - Co-Founder & Chairman Louis Scafuri - Chief Executive Officer Assaf Korner - ...

5 months ago - Seeking Alpha